August 07, 2018
Sage Therapeutics
Sage Therapeutics Announces Second Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
August 07, 2018
Sesen Bio
Sesen Bio Announces CEO and Board Transitions as Company Prepares for 12-Month Vista Trial Data and Regulatory Submission in 2019
August 07, 2018
Zafgen
Zafgen Reports Second Quarter 2018 Operating and Financial Results
August 06, 2018
bluebird bio
bluebird bio and Regeneron Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
August 06, 2018
Casma Therapeutics
Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice Presidents